Method For Treating Primary Insomnia

Patent No. EP1441702 (titled "Method For Treating Primary Insomnia") was filed by Neurim Pharmaceuticals on Aug 12, 2002. The application was issued on May 10, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ORIFARM GENERICSApr 8, 2020ZBM PATENTS APS
TEVA PHARMACEUTICALSFeb 12, 2018ELKINGTON AND FIFE
ASPIRE PHARMAFeb 9, 2018BROWN
GENERICS UKFeb 9, 2018COOKE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1441702

NEURIM PHARMACEUTICALS
Application Number
EP02760523A
Filing Date
Aug 12, 2002
Status
Revoked
Jan 29, 2021
Publication Date
May 10, 2017